The replication of the Nipah virus's genetic material in infected cells has been demonstrated for the first time by ...
NanoViricides, Inc. (the “Company”)(NYSE American:NNVC), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that the viruses cannot escape, declared today that its ...